Labcyte

BLOG

MONDAY, APRIL 25, 2016

Improved Cell Screening Shows Promise for Leukemia Patients

In an article recently published by In Vivo: Business & Medicine Report, author Mark Ratner writes about the growing use of high-throughput cell screening to identify combinations of therapeutics that are effective against cancer.
Read More

MONDAY, APRIL 25, 2016

Acoustic Liquid Handling Is Making Personalized Medicine a Reality

Labcyte Senior Research Fellow Joe Olechno has a new article in Personalized Medicine in Oncology that offers an informative view of how the Echo® Liquid Handler based on acoustic droplet ejection technology has been instrumental in recent efforts using ex vivo cell assays to inform individualized treatment decisions.
Read More

THURSDAY, APRIL 21, 2016

At SynBioBeta London, a Maturing Field Garners Industrial Interest

The Labcyte team was delighted to participate in the recent SynBioBeta meeting held in London. It’s the second year we’ve exhibited at this great event, and it was gratifying to find that even more people there have been using our tools to propel their synthetic biology projects forward.
Read More

THURSDAY, MARCH 24, 2016

VISIT US at BOOTH 536 @ #AACR16 for Sound Cancer Research Ideas

Did you know that Labcyte’s acoustic liquid handling technology can be used to conduct ex vivo drug screening on patient cells to identify cancer treatments likely to work in vivo? Exciting new research from our customers is opening doors to potential new strategies for cancer management that could provide more targeted and more personalized therapies.
Read More

FRIDAY, MARCH 11, 2016

Labcyte Receives Scientists’ Choice Award for Customer Video

We were proud to learn that our video interview with Dr Allan Jordan, Head of Chemistry, Drug Discovery Unit, Cancer Research UK Manchester Institute was selected by SelectScience as the Most Successful Video of 2015!
Read More

MONDAY, MARCH 07, 2016

Scientists Love Acoustic Liquid Handling

A new special issue of the Journal of Laboratory Automation (JALA) features more than 20 articles – covering more than 200 pages of peer-reviewed scientific reports – that highlight the revolutionary nature of acoustic droplet ejection (ADE) across a diverse range of scientific challenges. ADE has been widely accepted as the state-of-the-art liquid handling solution in high-throughput screening for drug discovery, and now this unique technology is having a powerful impact on a rapidly growing set of applications, including personalized medicine, synthetic biology, and drug combination therapy.
Read More